All Articles

A new deal between genomics giant Illumina and startup Bifrost Biosystems isn't just a business transaction. It’s a strategic play to rewire the very process of drug discovery.

FanDuel's expansion into Alberta signals a major shift in Canada's iGaming landscape, promising economic boons, intense competition, and a new era for fans.

As AI moves from training to production, a new infrastructure battle begins. DeepInfra's Canadian expansion reveals the race for low-latency, global inference.

Palo Alto startup Teamily AI launches a social platform where AI agents work alongside humans, aiming to revolutionize how companies are built and grown.

Chevron's new licensing deal with ZL Chemicals is more than a press release. It's a strategic masterstroke in monetizing dormant IP and reshaping the EOR market.

A new service moves beyond data, using AI and human guides to steer patients to affordable care. Is this the strategy that finally bends the healthcare cost curve?

At 70, Bay Cities isn't just surviving; it's thriving. A deep dive into how its 100% employee-owned model fuels record growth and future-proofs its strategy.

With a new name and $35M in fresh funding, Allotera Therapeutics is doubling down on a pivotal trial for Sofi-cel, a therapy aimed at solving a tough T-cell cancer.

A new partnership between Robust.AI and ShipLab reveals a phased, pay-for-performance model that could finally unlock warehouse automation for the masses.

Sandler's new platform moves past theory, using AI to evaluate seller skills in live conversations. Is this the key to finally solving sales training's ROI problem?

A new breed of AI agent from Rulebase promises to do what humans can’t: relentlessly chase stalled financial accounts until the revenue is secured.

After a long legal battle, a fabled Cuban beer returns to its founding family, reclaiming its identity and offering a taste of history to a new generation.

Fabletics' new golf line isn't just about style; it's a calculated move using a powerful data-driven membership model to disrupt a traditional industry.

As CCOs face unprecedented challenges from AI and shifting rules, Comply's upcoming ComplyConnect 2026 conference offers a critical forum for real-world strategy.

Philips' new Alturion ultrasound system promises efficiency with AI. But can it solve the deeper issues of staff burnout and diagnostic inconsistency?

CorePlus's landmark integration of an AI-powered test marks a pivotal moment for personalized medicine and health equity in the Caribbean.

A new platform is betting that behavioral data, not headhunters, is the key to success in law and finance. Can an algorithm really fix hiring?

New AI tools are moving beyond if a cognitive task is done to how. This shift promises earlier detection, personalized care, and a new era for brain health.

A new, free online hub helps Ontario families navigate the chaos of catastrophic injury, offering clear guidance on care, rehab, and complex insurance systems.